Literature DB >> 20928988

Peritonitis in a pediatric dialysis unit: local profile and implications.

Roxana Cleper1, Miriam Davidovits, Yael Kovalski, Dmitry Samsonov, Jacob Amir, Irit Krause.   

Abstract

BACKGROUND: Peritonitis is a major complication of chronic peritoneal dialysis therapy. It is recommended that each center monitor infection rates in order to define the local microbiological profile and implement an appropriate empiric antibiotic regimen.
OBJECTIVES: To analyze the microbiologic profile of peritonitis in our pediatric dialysis unit and identify local predisposing factors.
METHODS: In this retrospective study we reviewed the files of children treated with chronic PD during the 10 year period 1997-2007.
RESULTS: Eighty peritonitis episodes were recorded in 29 children (20 male, 9 female) aged 0.1-18.5 years (median 11.75) treated with peritoneal dialysis for 6-69 months (median 19) for a total of 578 patient-months. The annual peritonitis rate was 1.66/patient. The main pathogens were coagulase-negative Staphyloccocus (32.5%) and Pseudomonas spp. (16%), which were also cultured in most cases (64-69%) from the exit site during the 3 months preceding peritonitis. No peritonitis occurred in 31% of the patients (median age 12.5 years). All patients less than 5 years old had at least one peritonitis episode. Contaminating conditions (gastrostomy, enuresis, diaper use), found in 44% of the study group, and first infection within 6 months from starting PD were significantly associated with an increased peritonitis rate (P = 0.01, P = 0.009, respectively). Recurrent peritonitis led to a switch to hemodialysis in 18% of patients. There were no deaths.
CONCLUSIONS: The risk factors for peritonitis in our study were: first infection within less than 6 months from starting treatment, Pseudomonas exit-site colonization, and contaminating conditions (gastrostomies, diaper use, enuresis). These susceptible subgroups as well as very young age (< 5 years) at starting PD should be especially targeted during training of caregivers and follow-up to prevent later complications.

Entities:  

Mesh:

Year:  2010        PMID: 20928988

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  6 in total

Review 1.  A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis.

Authors:  Anouk T N van Diepen; Sarbjit V Jassal
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

Review 2.  Peritoneal dialysis associated infections: An update on diagnosis and management.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-08-06

3.  The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.

Authors:  Anouk T N van Diepen; George A Tomlinson; Sarbjit V Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

4.  [Bacteriological characteristics of the peritoneal dialysis fluid infections].

Authors:  Manel Jellouli; Meriem Ferjani; Kamel Abidi; Yosra Hammi; Taieb Ben Abdallah; Tahar Gargah
Journal:  Pan Afr Med J       Date:  2015-10-20

Review 5.  Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis.

Authors:  Cibele Grothe; Mônica Taminato; Angélica Belasco; Ricardo Sesso; Dulce Barbosa
Journal:  BMC Nephrol       Date:  2016-08-15       Impact factor: 2.388

6.  Brucella Peritonitis in a Patient on Peritoneal Dialysis: A Case Report and Review of Literature.

Authors:  Saeed M Al Zabali; Aljawharah K Rubaihan; Madawi F Alnetaifat; Salem Alshahrani; Moza Alhammadi
Journal:  Cureus       Date:  2021-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.